帝斯曼-芬美意以22亿欧元出售动物营养与健康业务

Core Viewpoint - DSM-Firmenich is selling its Animal Nutrition and Health (ANH) business to CVC Capital Partners for approximately €2.2 billion, marking a strategic shift towards becoming a pure consumer goods company focused on nutrition, health, and beauty [3]. Group 1: Transaction Details - The total value of the ANH business, including previous sales, will reach €3.7 billion by 2025 [3]. - The transaction will provide DSM-Firmenich with around €1.2 billion in cash, debt transfer, and seller loans, while retaining a 20% stake in the divested ANH business [3]. - A performance-based component of the purchase price, up to €500 million, will be contingent on future performance [3]. Group 2: Strategic Implications - The sale completes DSM-Firmenich's strategic realignment, allowing the company to focus on its core areas of nutrition, health, and beauty [3]. - The CEO emphasized that the company has achieved all strategic milestones since the merger in May 2023, and this sale represents the final step in its transformation into a leading consumer goods company [4]. Group 3: Financial Outlook - Analysts express concerns that the announced €500 million share buyback plan is disappointing, indicating potential debt issues related to the ANH business [3]. - The company is expected to report a non-cash impairment loss of approximately €1.9 billion in 2025, with the ANH business's financial performance being classified as "discontinued operations" [4]. - Analysts predict only modest growth in the upcoming quarterly results, which may not significantly stimulate the market [4].